Related Experiment Videos
Long-term prognosis in malignant or accelerated hypertension
C Guerin1, R Gonthier, F C Berthoux
1Faculté de Médecine, Hôpital Nord, Saint-Priest-en-Jarez, France.
Summary
Malignant hypertension significantly impacts survival, with 70% of patients experiencing renal death or requiring dialysis within the study period. Blood pressure control benefits heart and brain health but not kidney outcomes in these high-risk patients.
Area of Science:
- Nephrology
- Cardiology
- Neurology
Background:
- Malignant hypertension is a severe form of hypertension.
- Early diagnosis and management are crucial for patient outcomes.
Purpose of the Study:
- To analyze patient and kidney survival rates in patients with malignant hypertension.
- To identify risk factors for mortality and renal failure.
Main Methods:
- Retrospective analysis of 51 consecutive patients with malignant hypertension.
- Data collected between 1976 and 1981.
- Assessment of patient and kidney survival at 5-year and last follow-up.
Main Results:
- At 5 years, patient survival was 72.5% and kidney survival was 47%.
- At last follow-up, 35% of patients died and 35% required dialysis (70% renal death).
- Higher risk identified in patients with serum creatinine > 200 µmol/l on admission.
Conclusions:
- Malignant hypertension is associated with poor long-term patient and kidney survival.
- Blood pressure control improves cardiovascular and cerebrovascular outcomes but not renal outcomes.
- Serum creatinine levels on admission are a key predictor of risk.